Kaplan-Meier analysis and log-rank test revealed a stepwise reduced DSS (Figure 2a) and 5-year OS (Figure 2b) with decreasing RBM3 expression, with the shortest DSS (p<0.001) and 5-year OS (p<0.001) for patients with tumours lacking RBM3 expression. This evidence concerns the gene RBM3 and neoplasm.